1-5 of 5
Maria Jose Terol Castera
Close
Sort by
Journal Articles

Digital PCR Assay for Evaluation of CD19-CAR-T Cells In Vivo Expansion in Aggressive B-Cell Lymphoma: Impact on Clinical Outcome

Laura Ventura, Alicia Serrano, Blanca Ferrer Lores, Rafael Hernani, Alexandru Robert Vasile Tudorache, Ana Isabel Teruel, Ana Saus Carreres, Alfonso Ortiz Algarra, Ignacio Arroyo Martin, Juan Carlos Hernandez Boluda, Jose Luis Pinana Sanchez, Ariadna Perez, Ana Benzaquen, Carlos Solano, Maria Jose Terol Castera
Journal: Blood
Blood (2023) 142 (Supplement 1): 7153.
https://doi.org/10.1182/blood-2023-188300
Published: 2023
Journal Articles

Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy

Matthew G. Mei, Gaetano Corazzelli, Frank Morschhauser, Elizabeth Phillips, Graham P. Collins, Hun Ju Lee, Steve M Ansell, Craig H. Moskowitz, Nathalie A. Johnson, John Kuruvilla, Martin Hutchings, María José Terol Castera, George Hawkins, Anna Vossenkaemper, Teresa Collins, Robin Lesley, Emma Dean, Ting Yu, Connor Hall, Virginie Cerec, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2023-180926
Published: 2023
Journal Articles

Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Jose Garcia-Marco, MD PhD, Patricia Baltasar Tello, Esther González Garcia, Dra., Eduardo Ríos Herranz, MD, Angel Ramirez Payer, María José Terol Castera, Diana Champ, Angeles Medina Perez, Mercedes Gironella, Alicia Rodríguez Fernández, Ana Muntañola Prat, Alexia Suárez Cabrera, Manuel Jurado Chacón, Miguel Fernández Zarzoso, Mercedes Rodríguez, Juana Clavel, Maria Victoria Dourdil Sahun, Christelle M Ferra Coll, Ernesto Pérez Persona, Carmen Milagros Marrero Santos, Rafael Forés, Julio Delgado, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4321.
https://doi.org/10.1182/blood.V130.Suppl_1.4321.4321
Published: 2017
Journal Articles

Response-Adapted Treatment with Rituximab/Bendamustine/Mitoxantrone/Dexamethasone and Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma in Relapse or Refractory to First-Line Treatment with Immunochemotherapy. RBMDGELTAMO08 Trial

Francisco Javier Peñalver Párraga, José Antonio Márquez Navarro, Soledad Durán Nieto, Pilar Giraldo Castellano, Carlos Montalbán Sanz, María José Ramírez Sánchez, Juan-Manuel Sancho Cia, María José Terol Castera, Francisco Javier Capote Huelva, Antonio Gutiérrez García, Blanca Sánchez González, Antonio Salar Silvestre, Miguel Canales Albendea, MD PhD, María Dolores Caballero Barrigón
Journal: Blood
Blood (2016) 128 (22): 1788.
https://doi.org/10.1182/blood.V128.22.1788.1788
Published: 2016
Journal Articles

Prognostic Impact of the New CLL-IPI Index in a Single Center CLL Spanish Cohort

Blanca Ferrer Lores, MD, Blanca Navarro Cubells, PhD, Alicia Serrano Alcala, Biotechnologist, Ivan Castillo Martin, PhD, Anabel Teruel Casasus, MD, Sandra Ballester Martinez, PhD, Ariadna Perez Martinez, MD, Ana Mauricio Campos, MD, Inmaculada Castillo Valero, MD, Horacio Cano Gracia, MD, Carlos Solano Vercet, PhD, María José Terol Casterá, PhD
Journal: Blood
Blood (2016) 128 (22): 2019.
https://doi.org/10.1182/blood.V128.22.2019.2019
Published: 2016